- Home
- GGT vs NVCT Comparison
GGT vs NVCT Comparison
Compare GGT & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGT
- NVCT
- Stock Information
- Founded
- GGT 1994
- NVCT 2020
- Country
- GGT United States
- NVCT United States
- Employees
- GGT N/A
- NVCT N/A
- Industry
- GGT Trusts Except Educational Religious and Charitable
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- GGT Finance
- NVCT Health Care
- Exchange
- GGT Nasdaq
- NVCT Nasdaq
- Market Cap
- GGT 138.5M
- NVCT 119.4M
- IPO Year
- GGT N/A
- NVCT 2022
- Fundamental
- Price
- GGT $4.75
- NVCT $6.76
- Analyst Decision
- GGT
- NVCT Strong Buy
- Analyst Count
- GGT 0
- NVCT 1
- Target Price
- GGT N/A
- NVCT $21.00
- AVG Volume (30 Days)
- GGT 59.7K
- NVCT 82.1K
- Earning Date
- GGT 01-01-0001
- NVCT 11-06-2024
- Dividend Yield
- GGT 15.56%
- NVCT N/A
- EPS Growth
- GGT N/A
- NVCT N/A
- EPS
- GGT 0.83
- NVCT N/A
- Revenue
- GGT N/A
- NVCT N/A
- Revenue This Year
- GGT N/A
- NVCT N/A
- Revenue Next Year
- GGT N/A
- NVCT N/A
- P/E Ratio
- GGT $6.90
- NVCT N/A
- Revenue Growth
- GGT N/A
- NVCT N/A
- 52 Week Low
- GGT $4.32
- NVCT $5.85
- 52 Week High
- GGT $7.00
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- GGT 34.81
- NVCT 61.30
- Support Level
- GGT $4.70
- NVCT $6.40
- Resistance Level
- GGT $4.95
- NVCT $6.65
- Average True Range (ATR)
- GGT 0.06
- NVCT 0.33
- MACD
- GGT -0.01
- NVCT 0.07
- Stochastic Oscillator
- GGT 16.96
- NVCT 90.53
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.